R&D Why are eCOA studies still so challenging? Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
Digital Integration: The key to scalable decentralised trials Successful DCTs depend less on the technology deployed and more on how effectively those capabilities are integrated and executed.
R&D Sponsored Company Profile – Inventus Inventus devices and technology solutions have been deployed in 1,000+ clinical trials and are certified in 70+ countries.
Digital How integrated patient experience platforms are revolutionis... AI-powered integrated platforms offer an elemental shift in the way that clinical trials are conducted.
Digital Everyday drug discovery: How tech expands the potential of c... Discover how technology is making clinical trials more flexible and patient-friendly through tools like eCOA, eConsent, and wearables.
Digital Enhancing rare disease trials: eCOA technology’s impact on s... Sickle cell disease (SCD) affects an estimated 20 million people worldwide.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
